Abbott Labs, which makes the AIDS tablet Kaletra, announced today it won't sell any new drugs in Thailand, because the Thai government has been breaking patents on its AIDS medicines. Sarah Gardner reports.
GlaxoSmithKline's new drug Tykerb has won FDA approval to treat aggressive late-stage breast cancer. It could be a blockbuster — for investors and patients.
The U.S. is the only economic powerhouse that doesn't guarantee its workers paid sick days. A bill to be introduced in Congress today would change that, but business groups are likely to lobby against it.
The Broad Institute will receive $100 million — the biggest award ever given for psychiatric disease research — to analyze thousands of genetic samples from people with schizophrenia and bipolar disorder.
Los Angeles County officials are considering whether to give Hepatitis A vaccinations to some 100,000 food-service workers after an infected cook was found to be working for a local catering company. Helen Palmer reports.
The FDA has approved Tekturna, the first new class of hypertension drug in a decade. Tekturna controls blood pressure for a full 24 hours, but will that edge be enough to compete in a mature market full of cheap generics?
President Bush announced his plans to investigate the problems at Walter Reed Army Medical Center. Kai Ryssdal talks with expert Gordon Adams about some of the causes for those problems.
A special congressional advisory committee met today to try to find ways to curb Medicare costs. As Helen Palmer reports, they may want to provide better incentives to physicians.
McDonald's was none too happy after Prince Charles reportedly called for a ban on the fast food burger giant, but it has found an unlikely champion in the fallout.
